G1 Therapeutics Inc

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Report date

6/30/2024

Quarter

2024 Q2

Filed

8/12/2024

Shares

137,921

Value ($000)

314

Weight

0.0%

2019 Q4 - 2024 Q2 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q2	8/12/2024	314	0.0%	137,921	6/30/2024
2024 Q1	5/9/2024	93	0.0%	21,516	3/31/2024
2023 Q4	2/6/2024	66	0.0%	21,516	12/31/2023
2023 Q3	11/8/2023	31	0.0%	21,516	9/30/2023
2023 Q2	8/10/2023	597	0.0%	239,609	6/30/2023
2023 Q1	5/12/2023	548	0.0%	204,364	3/31/2023
2022 Q4	2/13/2023	994	0.0%	183,118	12/31/2022
2022 Q3	11/14/2022	2,260	0.0%	180,891	9/30/2022
2022 Q2	8/15/2022	768	0.0%	155,315	6/30/2022
2022 Q1	5/13/2022	2,025	0.0%	266,345	3/31/2022
2021 Q4	2/11/2022	2,662	0.0%	260,701	12/31/2021
2021 Q3	11/16/2021	3,223	0.0%	240,133	9/30/2021
2021 Q2	8/16/2021	5,262	0.0%	239,804	6/30/2021
2021 Q1	5/17/2021	5,456	0.0%	226,750	3/31/2021
2020 Q4	2/16/2021	3,626	0.0%	201,518	12/31/2020
2020 Q3	11/13/2020	2,322	0.0%	200,999	9/30/2020
2020 Q2	8/20/2020	4,841	0.0%	199,539	6/30/2020
2020 Q1	5/15/2020	2,055	0.0%	186,458	3/31/2020
2019 Q4	2/7/2020	4,834	0.0%	182,880	12/31/2019